Published in J Nucl Cardiol on August 04, 2008
Advances in molecular imaging with ultrasound. Mol Imaging (2010) 1.42
Cardiovascular therapeutic uses of targeted ultrasound contrast agents. Cardiovasc Res (2009) 1.24
Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating. J Acoust Soc Am (2013) 1.01
Contrast ultrasound molecular imaging of inflammation in cardiovascular disease. Cardiovasc Res (2009) 0.98
Diagnostic and therapeutic strategies for small abdominal aortic aneurysms. Nat Rev Cardiol (2011) 0.97
Whole animal imaging. Wiley Interdiscip Rev Syst Biol Med (2010) 0.94
Non-invasive imaging of vascular inflammation. Front Immunol (2014) 0.81
Acoustic radiation force for vascular cell therapy: in vitro validation. Ultrasound Med Biol (2012) 0.81
Molecular ultrasound imaging and its potential for paediatric radiology. Pediatr Radiol (2010) 0.78
Practical Methods for Molecular In Vivo Optical Imaging. Curr Protoc Cytom (2012) 0.77
Emerging diagnostic and therapeutic molecular imaging applications in vascular disease. Vasc Med (2011) 0.76
Noninvasive cardiovascular imaging techniques for basic science research: application to cellular therapeutics. Rev Esp Cardiol (2009) 0.75
Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes. Contrast Media Mol Imaging (2014) 0.75
Inflammation in atherosclerosis. Nature (2002) 28.92
Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation (1998) 5.93
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation (2003) 3.15
Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation (2001) 2.70
Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation (2003) 2.67
Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation (1998) 2.57
Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol (2004) 2.45
Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation (2007) 2.40
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res (2005) 2.34
Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol (2006) 2.21
Myocardial ischemic memory imaging with molecular echocardiography. Circulation (2007) 2.13
Angiogenesis: where do we stand now? Circulation (2005) 2.08
Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation (2000) 2.07
Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation (2005) 2.04
Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr (2002) 1.85
Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation (2003) 1.83
Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release (2004) 1.81
Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation (1994) 1.79
Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng (2002) 1.59
Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging (2006) 1.58
Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng (2005) 1.53
Basic acoustic properties of microbubbles. Echocardiography (2002) 1.49
Detection of coronary stenoses at rest with myocardial contrast echocardiography. Circulation (2005) 1.49
In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol (1999) 1.49
In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res (1994) 1.48
Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol (2007) 1.47
Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J (2007) 1.47
Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol (1998) 1.46
Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation (2000) 1.43
Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. J Pharm Sci (2001) 1.42
Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation (2000) 1.39
Deformable gas-filled microbubbles targeted to P-selectin. J Control Release (2006) 1.37
Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation (2002) 1.34
Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol (2007) 1.31
Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J (2001) 1.23
Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imaging (2006) 1.23
Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol (2004) 1.22
Contrast harmonic intravascular ultrasound: a feasibility study for vasa vasorum imaging. Invest Radiol (2006) 1.14
Influence of microbubble shell properties on ultrasound signal: Implications for low-power perfusion imaging. J Am Soc Echocardiogr (2002) 1.12
Effect of microbubble ligation to cells on ultrasound signal enhancement: implications for targeted imaging. Invest Radiol (2006) 1.05
Detection of coronary artery stenosis with power Doppler imaging. Circulation (2001) 1.03
Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectr Freq Control (2002) 1.00
Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol (1996) 1.00
Selectin ligands promote ultrasound contrast agent adhesion under shear flow. Mol Pharm (2006) 1.00
Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol (2007) 0.95
Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol (2000) 0.93
Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent. J Am Coll Cardiol (2002) 0.85
AI-700 pharmacokinetics, tissue distribution and exhaled elimination kinetics in rats. Int J Pharm (2006) 0.84